Michelle Shayne

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. doi request reprint The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents
    Michelle Shayne
    University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA
    J Cancer Surviv 8:167-72. 2014
  2. ncbi request reprint Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
    Michelle Shayne
    James P Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY 14642, USA
    Breast Cancer Res Treat 100:255-62. 2006
  3. ncbi request reprint Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
    Michelle Shayne
    Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Cancer 110:1611-20. 2007
  4. doi request reprint Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy
    Michelle Shayne
    Department of Medicine, University of Rochester and the James P Wilmot Cancer Center, Rochester, NY, USA
    Cancer 115:5319-28. 2009
  5. doi request reprint Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies
    Michelle Shayne
    University of Rochester Medical Center, Rochester, NY, USA
    J Geriatr Oncol 4:310-8. 2013
  6. pmc Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy
    Joseph A Roscoe
    University of Rochester James P Wilmot Cancer Center, Rochester, NY 14642, United States
    J Psychosom Res 71:423-8. 2011
  7. doi request reprint Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score
    Bradley M Turner
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA
    Mod Pathol 28:921-31. 2015
  8. doi request reprint A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
    Ping Tang
    Department of Pathology, University of Rochester of Rochester Medical Center, New York, USA
    Cancer Invest 28:978-82. 2010
  9. pmc Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial
    Charles E Heckler
    Department of Surgery, University of Rochester James P Wilmot Cancer Center, 265 Crittenden Blvd CU 420658, Rochester, NY, 14642, USA
    Support Care Cancer 24:2059-66. 2016
  10. doi request reprint Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expression
    Zhang Zhang
    Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA Department of Pathology, West China Hospital, Sichuan University, Sichuan, China
    Histopathology 65:508-16. 2014

Collaborators

Detail Information

Publications14

  1. doi request reprint The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents
    Michelle Shayne
    University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA
    J Cancer Surviv 8:167-72. 2014
    ..Training programs currently focus on treatment, while survivorship care focuses on time after treatment. Cancer survivorship training represents an education paradigm shift...
  2. ncbi request reprint Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
    Michelle Shayne
    James P Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY 14642, USA
    Breast Cancer Res Treat 100:255-62. 2006
    ..This retrospective study was undertaken to define risk factors for reductions in dose intensity of adjuvant chemotherapy in women with early stage breast cancer (ESBC)...
  3. ncbi request reprint Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
    Michelle Shayne
    Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Cancer 110:1611-20. 2007
    ..This prospective study was undertaken to evaluate patient and treatment characteristics that contribute to hematologic toxicity in older cancer patients...
  4. doi request reprint Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy
    Michelle Shayne
    Department of Medicine, University of Rochester and the James P Wilmot Cancer Center, Rochester, NY, USA
    Cancer 115:5319-28. 2009
    ..This prospective study evaluated patient and treatment characteristics that contributed to hematologic toxicity in older breast cancer patients treated with curative intent in the community setting...
  5. doi request reprint Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies
    Michelle Shayne
    University of Rochester Medical Center, Rochester, NY, USA
    J Geriatr Oncol 4:310-8. 2013
    ..There is limited understanding of risk factors that contribute to prolonged hospitalization and mortality in older patients with solid tumors...
  6. pmc Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy
    Joseph A Roscoe
    University of Rochester James P Wilmot Cancer Center, Rochester, NY 14642, United States
    J Psychosom Res 71:423-8. 2011
    ..However, little objective evidence has been gathered on the patterns of sleep before and following chemotherapy...
  7. doi request reprint Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score
    Bradley M Turner
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA
    Mod Pathol 28:921-31. 2015
    ..The information needed is already generated by many pathology laboratories during the initial assessment of primary breast cancer, and the equations are free. ..
  8. doi request reprint A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
    Ping Tang
    Department of Pathology, University of Rochester of Rochester Medical Center, New York, USA
    Cancer Invest 28:978-82. 2010
    ..926 (mitosis) -2.408 (PR) -1.061 (HER2) + 7.051 (luminal A) + 29.172 (luminal B) predicts RS with an R² of 0.65. In conclusion, PR negativity, luminal B subtype, tubal formation, and mitosis are strongly correlated with a higher RS...
  9. pmc Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial
    Charles E Heckler
    Department of Surgery, University of Rochester James P Wilmot Cancer Center, 265 Crittenden Blvd CU 420658, Rochester, NY, 14642, USA
    Support Care Cancer 24:2059-66. 2016
    ..Herein, we examine the effect of CBT-I, with and without A, on fatigue in cancer survivors...
  10. doi request reprint Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expression
    Zhang Zhang
    Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA Department of Pathology, West China Hospital, Sichuan University, Sichuan, China
    Histopathology 65:508-16. 2014
    ..This study will analyse the relationships between levels of ER expression and clinicopathological features and clinical outcomes, with an emphasis on the ER 1-10% subgroup...
  11. doi request reprint Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression
    Sanjib Banerjee
    Department of Surgery, University of Rochester Medical Center, Rochester, New York 14642, USA
    Cancer Res 71:318-27. 2011
    ..Thus, our data demonstrate a novel immune escape and tumor growth-supporting mechanism mediated by soluble Hsp27 that may be operative in human breast cancer...
  12. pmc An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea
    Joseph A Roscoe
    University of Rochester James P Wilmot Cancer Center, Rochester, New York 14642, USA
    J Pain Symptom Manage 40:379-90. 2010
    ..Previous research has shown that the effectiveness of acupressure bands in reducing chemotherapy-related nausea is related to patients' expectations of efficacy...
  13. ncbi request reprint Granulocyte colony-stimulating factors: finding the right indication
    Gary H Lyman
    University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Curr Opin Oncol 19:299-307. 2007
    ..Recommendations for the use of recombinant myeloid growth factors to reduce the risk of neutropenic complications and sustain dose intensity continue to evolve...
  14. pmc Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research
    MICHELLE C JANELSINS
    Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, James P Wilmot Cancer Center, USA
    J Cancer Sci Ther . 2011
    ..Additionally, clinical perspectives on symptom management and recommendations for areas of needed research are provided...